A Randomized Pilot Study of Inositol in Association with Betaine and Boswellia in the Management of Mastalgia and Benign Breast Lump in Premenopausal Women

Breast Cancer: Basic and Clinical Research

Original Research

Alessandra Cucina¹  Simona Dinicola²  Alessandro Giuliani³  Mariano Bizzarri⁴  Vittorio Pasta⁵  Francesco Tartaglia⁵  Saleh H. Alwasel⁶  Abdel Halim Harrath⁶ 

[1] Azienda Policlinico Umberto I, Rome, Italy.;Department of Surgery “Pietro Valdoni”, Sapienza University of Rome, Rome, Italy.;Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.;Department of Surgery “Pietro Valdoni”, Sapienza University of Rome, Rome, Italy.;Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy.;Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.;Systems Biology Group Lab, Sapienza University of Rome, Rome, Italy.;Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy.;Azienda Policlinico Umberto I, Rome, Italy.;Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.;

关键词: myoinositol;    benign breast diseases;    mastalgia;    boswellic acid;    betaine;   

DOI  :  10.4137/BCBCR.S38408

 received in 2015-12-30, accepted in 2016-02-21,  发布年份 2016

来源: Sage Journals

【 摘 要 】

Benign mammary lumps and mastalgia are the most common breast disorders; yet, there is no clear-cut consensus about the best strategy for their treatment. We hypothesized that a combination, including boswellic acid, betaine, and myoinositol, would be beneficial in breast disorders by exerting a pleiotropic effect on multiple pathways. Indeed, myoinositol has already been proven to modulate some factors involved in the genesis of breast diseases, such as fibrosis and metabolic and endocrine cues. In our study, 76 women were randomly assigned to either the experimental or the placebo arm. After six months of treatment, statistically significant differences between the two groups were recorded for pain relief (56% vs 17%) and breast density reduction (60% vs 9%). Furthermore, benign breast mass dimension showed a reduction in the experimental group (40% vs 16%). The combination of boswellic acid, betaine, and myoinositol has been demonstrated to be effective in the treatment of breast pain and radiologically and histologically confirmed benign breast mass and in the reduction of breast density, one of the pivotal risk factors for the development of breast cancer, without any side effects.

【 授权许可】

CC BY-NC   
© 2016 SAGE Publications.

【 图 表 】

Figure 4

Figure 6.

Figure 5.

Figure 7.

Figure 3.